The pot stocks are soaring again after a CBD-based drug took a step closer to commercial launch
September 27, 2018 at 11:23 AM EDT
Marijuana stocks ripped higher Thursday after the U.S. Drug Enforcement Administration classified a cannabidiol (CBD)-based drug made by GW Pharmaceuticals in its least restrictive category, setting the stage for commercial launch.